Table 23.6 Open in new tab Treatment of... | Oxford Academic

Table 23.6

Open in new tab

Treatment of tardive dyskinesia with tiapride

Reference	Number of patients	Length of treatment	Dose (mg/day)	Results
Buruma et al. (1982)	12	2 weeks	300	Significant effect
Murphy et al. (1982)	8	6 weeks	600–800	No significant effect
Rust (1983)	37	4 weeks to > 3 months	300–600	30 patients improved
Auberger et al. (1985)	21	12 weeks	600	Significant effect at weeks 6–8 of treatment
Pollak et al. (1985)	10	4 weeks	510 + 120	Three patients improved
Perenyi et al. (1985)	10	4 weeks	300–600	Reduced AIMS score, no significant effect
Leblhuber et al. (1987)	12	3 weeks	300	Significant effect
Diedrich and Müller (1989)	1	8 months	150	Complete improvement

Reference	Number of patients	Length of treatment	Dose (mg/day)	Results
Buruma et al. (1982)	12	2 weeks	300	Significant effect
Murphy et al. (1982)	8	6 weeks	600–800	No significant effect
Rust (1983)	37	4 weeks to > 3 months	300–600	30 patients improved
Auberger et al. (1985)	21	12 weeks	600	Significant effect at weeks 6–8 of treatment
Pollak et al. (1985)	10	4 weeks	510 + 120	Three patients improved
Perenyi et al. (1985)	10	4 weeks	300–600	Reduced AIMS score, no significant effect
Leblhuber et al. (1987)	12	3 weeks	300	Significant effect
Diedrich and Müller (1989)	1	8 months	150	Complete improvement

Reproduced with permission from Ebel H. Therapy of neuroleptic-induced extrapyramidal movement disorders. Neurol Psych Brain Res 1994; 2:140–151. © Elsevier.